ATE460430T1 - Kit zur untersuchung von menschlichem niedermolekulargewicht cd14 und antikörper - Google Patents

Kit zur untersuchung von menschlichem niedermolekulargewicht cd14 und antikörper

Info

Publication number
ATE460430T1
ATE460430T1 AT03772718T AT03772718T ATE460430T1 AT E460430 T1 ATE460430 T1 AT E460430T1 AT 03772718 T AT03772718 T AT 03772718T AT 03772718 T AT03772718 T AT 03772718T AT E460430 T1 ATE460430 T1 AT E460430T1
Authority
AT
Austria
Prior art keywords
human low
kit
antibodies
molecular weight
low molecular
Prior art date
Application number
AT03772718T
Other languages
English (en)
Inventor
Shoji Furusako
Kamon Shirakawa
Original Assignee
Mochida Pharm Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Mochida Pharm Co Ltd filed Critical Mochida Pharm Co Ltd
Application granted granted Critical
Publication of ATE460430T1 publication Critical patent/ATE460430T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/705—Receptors; Cell surface antigens; Cell surface determinants
    • C07K14/70596—Molecules with a "CD"-designation not provided for elsewhere
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies
    • C07K16/18—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • C07K16/28—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants
    • C07K16/2896—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants against molecules with a "CD"-designation, not provided for elsewhere
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2317/00—Immunoglobulins specific features
    • C07K2317/30—Immunoglobulins specific features characterized by aspects of specificity or valency
    • C07K2317/34—Identification of a linear epitope shorter than 20 amino acid residues or of a conformational epitope defined by amino acid residues
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2800/00—Detection or diagnosis of diseases
    • G01N2800/26—Infectious diseases, e.g. generalised sepsis

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Immunology (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Cell Biology (AREA)
  • Toxicology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Zoology (AREA)
  • Engineering & Computer Science (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Peptides Or Proteins (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Investigating Or Analysing Materials By The Use Of Chemical Reactions (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
AT03772718T 2002-11-12 2003-11-12 Kit zur untersuchung von menschlichem niedermolekulargewicht cd14 und antikörper ATE460430T1 (de)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
JP2002328866 2002-11-12
JP2003330775 2003-09-22
PCT/JP2003/014389 WO2004044005A1 (ja) 2002-11-12 2003-11-12 ヒト低分子量ｃｄ１４測定キットおよび抗体

Publications (1)

Publication Number Publication Date
ATE460430T1 true ATE460430T1 (de) 2010-03-15

Family

ID=32314082

Family Applications (1)

Application Number Title Priority Date Filing Date
AT03772718T ATE460430T1 (de) 2002-11-12 2003-11-12 Kit zur untersuchung von menschlichem niedermolekulargewicht cd14 und antikörper

Country Status (10)

Country Link
US (2) US7465547B2 (de)
EP (1) EP1571160B1 (de)
JP (1) JP4081489B2 (de)
CN (1) CN100558746C (de)
AT (1) ATE460430T1 (de)
AU (1) AU2003280753A1 (de)
CA (1) CA2506580C (de)
DE (1) DE60331677D1 (de)
ES (1) ES2340266T3 (de)
WO (1) WO2004044005A1 (de)

Families Citing this family (26)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7608684B2 (en) * 2002-11-12 2009-10-27 Mochida Pharmaceuticals Co., Ltd. Soluble CD14 antigen
AU2003280753A1 (en) 2002-11-12 2004-06-03 Mochida Pharmaceutical Co., Ltd. Kit for assaying human low-molecular weight cd14 and antibody
CN1968962B (zh) 2004-05-11 2013-07-24 持田制药株式会社 新型可溶性cd14抗原
KR101025723B1 (ko) * 2008-07-18 2011-04-04 주식회사 인포피아 광도파로를 포함하는 면역 크로마토그래피 분석 센서 및이를 이용한 측정방법
WO2012096245A1 (ja) * 2011-01-11 2012-07-19 三菱化学メディエンス株式会社 敗血症の予後の予測方法
WO2012133452A1 (ja) * 2011-03-28 2012-10-04 三菱化学メディエンス株式会社 全血検体の免疫測定方法および測定キット
CA2836562C (en) 2011-05-19 2021-04-27 Kamon Shirakawa Diagnosis of respiratory tract infectious disease using blood specimens
MX352625B (es) * 2011-05-19 2017-12-01 Mochida Pharm Co Ltd Diagnostico de la enfermedad infecciosa del tracto respiratorio usando especimenes de orina.
EP2743701B1 (de) * 2011-08-12 2016-04-27 LSI Medience Corporation Verfahren zum nachweis von infektionen an stellen einer operation
WO2014178383A1 (ja) * 2013-04-30 2014-11-06 持田製薬株式会社 プレセプシン測定による発熱性好中球減少症の診断
LT3628731T (lt) 2014-02-26 2021-08-10 Mochida Pharmaceutical Co., Ltd. Naujas antipresepsino antikūnas
JP6606552B2 (ja) * 2015-08-25 2019-11-13 持田製薬株式会社 特異的に精製された抗プレセプシン抗体
EP3551034A1 (de) 2016-12-07 2019-10-16 Progenity, Inc. Verfahren, vorrichtungen und systeme zur detektion des magen-darm-trakts
JP2018140961A (ja) * 2017-02-28 2018-09-13 持田製薬株式会社 ビオチン化ｆ１１０６−１３−３抗体、その製造方法及びその用途
EP3600416B1 (de) 2017-03-30 2023-06-07 Biora Therapeutics, Inc. Behandlung einer erkrankung des gastrointestinaltraktes mit einem immunmodulatorischen mittel, das mit einer einnehmbaren vorrichtung freigesetzt wird.
JP6842168B2 (ja) * 2017-05-12 2021-03-17 国立大学法人東北大学 マイクロ水滴内イムノアッセイ
US12227565B2 (en) 2018-06-20 2025-02-18 Biora Therapeutics, Inc. Method of formulating a pharmaceutical composition comprising administering an immune modulator to the small intestine
WO2019246312A1 (en) 2018-06-20 2019-12-26 Progenity, Inc. Treatment of a disease of the gastrointestinal tract with an immunomodulator
WO2020106757A1 (en) 2018-11-19 2020-05-28 Progenity, Inc. Ingestible device for delivery of therapeutic agent to the gastrointestinal tract
CN115232211B (zh) * 2019-11-19 2025-09-19 武汉全景生物技术有限公司 新的抗可溶性cd14亚型抗体及其应用
CN113892031B (zh) * 2019-11-19 2022-12-09 武汉全景生物技术有限公司 混合检测PCT和Presepsin的试剂盒、方法以及应用
CN121197633A (zh) 2019-12-13 2025-12-26 比特比德科有限责任公司 用于将治疗剂递送至胃肠道的可摄取装置
CN116500258A (zh) * 2022-01-18 2023-07-28 广州达安基因股份有限公司 基于夹心法荧光免疫层析定量检测cd14的试剂盒及其应用
EP4508434A1 (de) 2022-04-11 2025-02-19 bioMérieux Ptx3-biomarker zur verringerung der antibiotikabehandlung bei neugeborenen
CN114839253B (zh) * 2022-04-21 2024-10-01 深圳市第二人民医院(深圳市转化医学研究院) 血清或血浆中低分子量蛋白定量分析方法及应用
CN116444673B (zh) * 2023-06-14 2023-09-15 北京汇智和源生物技术有限公司 人源膜cd14单克隆抗体及其制备方法和应用

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4931385A (en) * 1985-06-24 1990-06-05 Hygeia Sciences, Incorporated Enzyme immunoassays and immunologic reagents
DD286876A5 (de) 1989-08-10 1991-02-07 Ernst-Moritz-Arndt-Universitaet Greifswald,De Verfahren zur bestimmung eines loeslichen humanen monozytenoberflaechenantigens
US5766593A (en) 1994-12-30 1998-06-16 Amgen Inc. Anti-inflammatory CD14 peptides
CA2355896A1 (en) * 1998-12-21 2000-06-29 Ludwig Institute For Cancer Research Antibodies to truncated vegf-d and uses thereof
US7326568B2 (en) * 1999-02-04 2008-02-05 University Of Georgia Research Foundation, Inc. Recombinant expression of heterologous nucleic acids in protozoa
WO2001022085A1 (en) 1999-09-17 2001-03-29 Mochida Pharmaceutical Co., Ltd. Method of fractional measurement of soluble cd14 protein
CA2404511A1 (en) * 2000-03-31 2001-10-04 Mochida Pharmaceutical Co., Ltd. Tlr/cd14 binding inhibitor
JPWO2002042333A1 (ja) * 2000-11-22 2004-03-25 持田製薬株式会社 Ｃｄ１４／ｔｌｒ結合阻害作用を有する抗ｃｄ１４モノクローナル抗体
AU2003280753A1 (en) 2002-11-12 2004-06-03 Mochida Pharmaceutical Co., Ltd. Kit for assaying human low-molecular weight cd14 and antibody

Also Published As

Publication number Publication date
DE60331677D1 (de) 2010-04-22
CN1711283A (zh) 2005-12-21
US20090029396A1 (en) 2009-01-29
EP1571160A1 (de) 2005-09-07
AU2003280753A1 (en) 2004-06-03
EP1571160B1 (de) 2010-03-10
JPWO2004044005A1 (ja) 2006-05-11
WO2004044005A1 (ja) 2004-05-27
US20070106067A1 (en) 2007-05-10
US7901900B2 (en) 2011-03-08
CA2506580A1 (en) 2004-05-27
US7465547B2 (en) 2008-12-16
CA2506580C (en) 2010-08-17
JP4081489B2 (ja) 2008-04-23
CN100558746C (zh) 2009-11-11
ES2340266T3 (es) 2010-06-01
EP1571160A4 (de) 2007-03-21

Similar Documents

Publication Publication Date Title
DE60331677D1 (de) Kit zur untersuchung von menschlichem niedermolekulargewicht cd14 und antikörper
EP2147928A3 (de) Auf Peptiden basierte Immunisierungstherapie zur Behandlung von Atherosklerose und Entwicklung von Peptid-basierten Assays zur Bestimmung von Immunreaktionen gegen oxidiertes Lipoprotein geringer Dichte
RU2009143671A (ru) Высокочувствительные иммуноанализы и наборы для определения представляющих интерес пептидов и белков
ATE517922T1 (de) Stabilisierte einzel-domänen-antikörper in einer pharmazeutischen zusammensetzung ausgestaltet für inhalation
EP2343318A3 (de) Antikörper die an ein C-terminales Fragment des Apolipoproteins E binden
EP2295465A3 (de) Menschliche monoklonale Antikörper gegen das Influenza M2 Protein sowie Methoden zu deren Herstellung und Verwendung
WO2004046194A3 (en) Polyclonal-monoclonal elisa assay for detecting n-terminus probnp
NO901899L (no) Hiv-peptider, syntetiske hiv-antigener og immunoanalysekit
DE60333471D1 (de) Polyklonaler-monoklonaler-elisa-assay zum nachweis von n-terminalem probnp
ATE335763T1 (de) Sandwich-immunoassay zur bestimmung von proanp- teilpeptiden
WO2001061305A3 (en) Immunoassays detecting or making use of at least two rubber latexallergens
DE60129239D1 (de) Kit und verfahren zur bestimmung von protein esm-1
DE502004000540D1 (de) Verfahren zur Bestimmung der Bildung von Endothelinen zu Zwecken der medizinischen Diagnostik, sowie Antikörper und Kits für die Durchführung eines solchen Verfahrens
BG106021A (bg) Метод за диагностика на трансмисивни спонгиозни енцефалопатии
CA2524002A1 (en) Sars-related proteins
ES2584982T3 (es) Procedimiento para el diagnóstico de infecciones de bacterias Propionibacterium
ATE360034T1 (de) Antikörper gegen metastin und dessen verwendung zur diagnose von schwangerschaft
WO2004003155A3 (en) Humanized anti-tag-72 cc49 for diagnosis and therapy of human tumors
WO2006004958A3 (en) Detection or measurement of antibodies to antigenic proteins in biological tissues or samples
RU2014102721A (ru) Способ получения агента, связывающегося с препро-вазопрессином или с его фрагментами
CA2505995A1 (en) Cobalamin assay
EP1780215A4 (de) Morbus-crohn-antikörperepitoppeptid und reagens zum testen auf morbus crohn
WO2004065936A3 (en) Immunoglobulin e detection in mammalian species
CA2488127A1 (en) Antibodies directed against prothrombin fragment f1+2, the preparation and use thereof
WO2002046769A3 (en) A monoclonal antibody-based diagnostic assay for gamma fibrinogen

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties